Rapport Therapeutics, Inc. RAPP Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s net income?
- Rapport Therapeutics, Inc. (RAPP) reported net income of -$19.86M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s net income changed year-over-year?
- Rapport Therapeutics, Inc.'s net income increased by 17.5% year-over-year, from -$24.06M to -$19.86M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s net income?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s net income has grown at a 79.0% compound annual growth rate (CAGR), from -$34.79M to -$111.48M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.